argenx SE (ARGX.BR)
ARGX.BR on Brussels Stock Exchange
103.20EUR
18 Apr 2019
103.20EUR
18 Apr 2019
Change (% chg)
€-0.60 (-0.58%)
€-0.60 (-0.58%)
Prev Close
€103.80
€103.80
Open
€102.10
€102.10
Day's High
€109.80
€109.80
Day's Low
€100.70
€100.70
Volume
268,726
268,726
Avg. Vol
118,393
118,393
52-wk High
€119.60
€119.60
52-wk Low
€54.30
€54.30
About
argenx SE, formerly arGEN X BV, is the Netherlands-based biopharmaceutical company. It creates and develops a pipeline of differentiated antibody therapeutics using its discovery platform, Simple Antibody, which exploits characteristics of the llama immune system. The Company develops a pipeline of antibody therapeutics focused... (more)
Overall
| Beta: | 0.54 |
| Market Cap(Mil.): | €3,889.87 |
| Shares Outstanding(Mil.): | 37.69 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| ARGX.BR | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 109.48 | 62.40 |
| EPS (TTM): | -1.97 | -- | -- |
| ROI: | -15.06 | 7.96 | 11.78 |
| ROE: | -15.09 | 8.11 | 12.61 |
Estimates